ScreenPoint Medical

About ScreenPoint Medical

ScreenPoint Medical specializes in breast imaging AI technology, notably the Transpara Breast AI suite, which assists radiologists in reading mammograms with improved workflow and confidence. The company emphasizes evidence-based solutions for breast cancer screening, including detection, density assessment, and temporal comparison to leverage prior studies. Its offerings are CE-marked and FDA-cleared for 2D and 3D mammography, and they target radiology departments and screening programs globally. Headquartered in the Netherlands, ScreenPoint Medical markets its products to healthcare providers seeking enhanced accuracy and efficiency in breast cancer screening.